PAOG Publishes 2022 Strategic Update
Sandusky, OH, Jan. 28, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy. The ...
Sandusky, OH, Jan. 28, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy. The ...
Sandusky, OH, Jan. 06, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed the development of a line of CBD nutraceutical products for Puration, Inc. (OTC Pink: ...
Sandusky, OH, Dec. 15, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full spectrum CBD products are now available for ...
Sandusky, OH, Nov. 08, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company adding bioidentical synthetic CBD to its overall research initiative. PAOG management highlights ...
Sandusky, OH, Oct. 28, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is entertaining a partnership opportunity to accelerate the ongoing development of its ...
Sandusky, OH, Oct. 18, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) earlier today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. ...